Authorea (Authorea),
Год журнала:
2023,
Номер
unknown
Опубликована: Сен. 27, 2023
Aims:
Conduct
a
systematic
review
of
case
reports
and
series
regarding
the
development
acute
abdomen
following
vaccination
with
COVID-19,
to
describe
in
detail
possible
association,
clinical
demographic
characteristics.
Methods:
Case
report
studies
COVID-19
were
included.
Systematic
studies,
literature,
letters
editor,
brief
comments,
etc.
excluded.
PubMed,
Scopus,
EMBASE,
Web
Science
databases
searched
until
June
15,
2023.
The
Joanna
Brigs
Institute
tool
was
used
assess
risk
bias
study
quality.
Descriptive
data
expressed
as
frequency,
median,
mean,
standard
deviation.
Results:
Seventeen
identified
17
patients
associated
evaluated,
including:
appendicitis
(n=3),
pancreatitis
(n=9),
diverticulitis
(n=1),
cholecystitis
(n=2)
colitis
(n=2).
most
vaccine
Pfizer-BioNTech
(mRNA)
64.71
%.
majority
cases
after
first
dose
(52.94
%).
All
responded
objectively
medical
(88.34
%)
surgical
(11.76
treatment
discharged
within
few
weeks.
There
no
death.
Conclusions:
Acute
is
rare
complication
great
interest
practice
vaccination,
our
reviewed
based
on
small
sample
patients,
therefore
it
recommended
conduct
future
observational
fully
elucidate
mechanisms
by
which
this
association
occurs.
Journal of Rural Medicine,
Год журнала:
2024,
Номер
19(3), С. 199 - 203
Опубликована: Янв. 1, 2024
Objective:
Since
the
onset
of
coronavirus
disease
2019
(COVID-19)
pandemic,
COVID-19
vaccination
has
substantially
reduced
mortality
and
hospitalization
rates
worldwide,
with
rare
adverse
events
reported
in
clinical
settings.
Herein,
we
present
a
case
acute
pancreatitis
complicated
by
diabetic
ketoacidosis
(DKA)
following
third
dose.
The Egyptian Journal of Internal Medicine,
Год журнала:
2024,
Номер
36(1)
Опубликована: Сен. 26, 2024
Abstract
Background
Vaccines
are
uncommon
causes
of
pancreatitis,
and
only
a
few
case
reports
have
described
COVID-19
vaccine-related
pancreatitis.
Case
presentation
A
45-year-old
male
patient
applied
to
the
emergency
department
due
having
serious
abdominal
pain.
Pfizer-BioNTech
vaccine,
last
dose
was
administered
1
week
ago.
One
after
vaccination,
he
experienced
Laboratory
tests
demonstrated
elevated
C-reactive
protein,
amylase,
lipase
levels,
Ig
G4
levels
were
normal.
Abdominal
computer
tomography
(CT)
displayed
acute
edematous
pancreatitis
peripancreatic
inflammatory
changes.
The
diagnosed
with
vaccine.
Conclusion
We
should
be
aware
that
induced
by
vaccine
may
occur
days
or
weeks
especially
in
patients
who
risk
factors
for
Authorea (Authorea),
Год журнала:
2023,
Номер
unknown
Опубликована: Сен. 27, 2023
Aims:
Conduct
a
systematic
review
of
case
reports
and
series
regarding
the
development
acute
abdomen
following
vaccination
with
COVID-19,
to
describe
in
detail
possible
association,
clinical
demographic
characteristics.
Methods:
Case
report
studies
COVID-19
were
included.
Systematic
studies,
literature,
letters
editor,
brief
comments,
etc.
excluded.
PubMed,
Scopus,
EMBASE,
Web
Science
databases
searched
until
June
15,
2023.
The
Joanna
Brigs
Institute
tool
was
used
assess
risk
bias
study
quality.
Descriptive
data
expressed
as
frequency,
median,
mean,
standard
deviation.
Results:
Seventeen
identified
17
patients
associated
evaluated,
including:
appendicitis
(n=3),
pancreatitis
(n=9),
diverticulitis
(n=1),
cholecystitis
(n=2)
colitis
(n=2).
most
vaccine
Pfizer-BioNTech
(mRNA)
64.71
%.
majority
cases
after
first
dose
(52.94
%).
All
responded
objectively
medical
(88.34
%)
surgical
(11.76
treatment
discharged
within
few
weeks.
There
no
death.
Conclusions:
Acute
is
rare
complication
great
interest
practice
vaccination,
our
reviewed
based
on
small
sample
patients,
therefore
it
recommended
conduct
future
observational
fully
elucidate
mechanisms
by
which
this
association
occurs.
